Rossetti L, Giaccari A, Barzilai N, Howard K, Sebel G, Hu M
Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461.
J Clin Invest. 1993 Sep;92(3):1126-34. doi: 10.1172/JCI116681.
To examine the relationship between the plasma glucose concentration (PG) and the pathways of hepatic glucose production (HGP), five groups of conscious rats were studied after a 6-h fast: (a) control rats (PG = 8.0 +/- 0.2 mM); (b) control rats (PG = 7.9 +/- 0.2 mM) with somatostatin and insulin replaced at the basal level; (c) control rats (PG = 18.1 +/- 0.2 mM) with somatostatin, insulin replaced at the basal level, and glucose infused to acutely raise plasma glucose by 10 mM; (d) control rats (PG = 18.0 +/- 0.2 mM) with somatostatin and glucose infusions to acutely reproduce the metabolic conditions of diabetic rats, i.e., hyperglycemia and moderate hypoinsulinemia; (e) diabetic rats (PG = 18.4 +/- 2.3 mM). All rats received an infusion of [3-3H]glucose and [U-14C]lactate. The ratio between hepatic [14C]UDP-glucose sp act (SA) and 2X [14C]-phosphoenolpyruvate (PEP) SA (the former reflecting glucose-6-phosphate SA) measured the portion of total glucose output derived from PEP-gluconeogenesis. In control rats, HGP was decreased by 58% in hyperglycemic compared to euglycemic conditions (4.5 +/- 0.3 vs. 10.6 +/- 0.2 mg/kg.min; P < 0.01). When evaluated under identical glycemic conditions, HGP was significantly increased in diabetic rats (18.9 +/- 1.4 vs. 6.2 +/- 0.4 mg/kg.min; P < 0.01). In control rats, hyperglycemia increased glucose cycling (by 2.5-fold) and the contribution of gluconeogenesis to HGP (91% vs. 45%), while decreasing that of glycogenolysis (9% vs. 55%). Under identical plasma glucose and insulin concentrations, glucose cycling in diabetic rats was decreased (by 21%) and the percent contribution of gluconeogenesis to HGP (73%) was similar to that of controls (84%). These data indicate that: (a) hyperglycemia causes a marked inhibition of HGP mainly through the suppression of glycogenolysis and the increase in glucokinase flux, with no apparent changes in the fluxes through gluconeogenesis and glucose-6-phosphatase; under similar hyperglycemic hypoinsulinemic conditions: (b) HGP is markedly increased in diabetic rats; however, (c) the contribution of glycogenolysis and gluconeogenesis to HGP is similar to control animals.
为研究血浆葡萄糖浓度(PG)与肝脏葡萄糖生成途径(HGP)之间的关系,对五组禁食6小时的清醒大鼠进行了研究:(a)对照大鼠(PG = 8.0±0.2 mM);(b)对照大鼠(PG = 7.9±0.2 mM),其生长抑素和胰岛素维持在基础水平;(c)对照大鼠(PG = 18.1±0.2 mM),生长抑素、胰岛素维持在基础水平,并输注葡萄糖使血浆葡萄糖急性升高10 mM;(d)对照大鼠(PG = 18.0±0.2 mM),输注生长抑素和葡萄糖以急性重现糖尿病大鼠的代谢状况,即高血糖和中度低胰岛素血症;(e)糖尿病大鼠(PG = 18.4±2.3 mM)。所有大鼠均接受[3-³H]葡萄糖和[U-¹⁴C]乳酸输注。肝脏[¹⁴C]UDP-葡萄糖比活性(SA)与2×[¹⁴C]-磷酸烯醇丙酮酸(PEP)SA的比值(前者反映葡萄糖-6-磷酸SA)可测定源自PEP-糖异生的总葡萄糖输出部分。在对照大鼠中,与血糖正常的情况相比,高血糖时HGP降低了58%(4.5±0.3对10.6±0.2 mg/kg·min;P<0.01)。在相同血糖条件下评估时,糖尿病大鼠的HGP显著增加(18.9±1.4对6.2±0.4 mg/kg·min;P<0.01)。在对照大鼠中,高血糖增加了葡萄糖循环(增加2.5倍)以及糖异生对HGP的贡献(91%对45%),同时降低了糖原分解的贡献(9%对55%)。在相同的血浆葡萄糖和胰岛素浓度下,糖尿病大鼠的葡萄糖循环减少(减少21%),糖异生对HGP的贡献百分比(73%)与对照大鼠(84%)相似。这些数据表明:(a)高血糖主要通过抑制糖原分解和增加葡萄糖激酶通量导致HGP显著抑制,而糖异生和葡萄糖-6-磷酸酶的通量无明显变化;在类似的高血糖低胰岛素血症条件下:(b)糖尿病大鼠的HGP显著增加;然而,(c)糖原分解和糖异生对HGP的贡献与对照动物相似。